Jushi Holdings (JUSHF) Tax Provisions (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Tax Provisions of -$976000.0 for Q2 2026, down 109.83% year-over-year from $9.9 million in Q2 2025, and down 111.2% quarter-over-quarter from $8.7 million in Q1 2026.
Jushi Holdings (JUSHF) Tax Provisions (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Tax Provisions for 6 consecutive years, with -$976000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Tax Provisions fell 109.83% year-over-year to -$976000.0; the TTM figure through Jun 2026 stood at $23.8 million (down 24.28% YoY), while the FY2025 annual figure was $35.0 million, up 10.62% from the prior year.
- Tax Provisions retreated to -$976000.0 in Q2 2026 per JUSHF's latest filing, from $8.7 million in the prior quarter.
- Across five years, Tax Provisions topped out at $10.1 million in Q1 2023 and bottomed at -$2.8 million in Q3 2022.
- Historically, Tax Provisions has averaged $6.4 million across 5 years, with a median of $8.3 million in 2023.
- Annual changes were most pronounced in 2022 — Tax Provisions sank 144.24% — and 2023, when it soared 437.59%.
- Jushi Holdings' Tax Provisions stood at -$1.5 million in 2022, then jumped by 437.59% to $5.1 million in 2023, then fell by 29.64% to $3.6 million in 2024, then jumped by 102.09% to $7.3 million in 2025, then sank by 113.46% to -$976000.0 in 2026.
- Business Quant data shows JUSHF's Tax Provisions at -$976000.0 in Q2 2026, $8.7 million in Q1 2026, and $7.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | -976,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -976,000.00 |
| Mar 31, 2026 | 8.72 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 8.83 Mn |
| Jun 30, 2025 | 9.93 Mn |
| Mar 31, 2025 | 8.98 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Sep 30, 2024 | 8.97 Mn |
| Jun 30, 2024 | 9.33 Mn |
| Mar 31, 2024 | 9.75 Mn |
| Dec 31, 2023 | 5.10 Mn |
| Sep 30, 2023 | 8.01 Mn |
| Jun 30, 2023 | 8.55 Mn |
| Mar 31, 2023 | 10.15 Mn |
| Dec 31, 2022 | -1.51 Mn |
| Sep 30, 2022 | -2.80 Mn |
| Jun 30, 2022 | 7.71 Mn |
| Mar 31, 2022 | 5.05 Mn |
| Dec 31, 2021 | 8.61 Mn |
| Sep 30, 2021 | 6.33 Mn |